Ankylosing spondylitis

The effect of comedication with conventional synthetic disease modifying antirheumatic drugs on TNF inhibitor drug survival in patients with ankylosing spondylitis and undifferentiated spondyloarthritis: results from a nationwide prospective study
Elisabeth Lie, Lars Erik Kristensen, Helena Forsblad-d'Elia, Tatiana Zverkova-Sandström, Johan Askling, Lennart T Jacobsson, for the ARTIS Study Group

Annals of the Rheumatic Diseases Jun 2015, 74 (6) 970-978; DOI: 10.1136/annrheumdis-2014-206616
Does spinal MRI add incremental diagnostic value to MRI of the sacroiliac joints alone in patients with non-radiographic axial spondyloarthritis?
Ulrich Weber, Veronika Zubler, Zheng Zhao, Robert GW Lambert, Stanley M Chan, Susanne J Pedersen, Mikkel Østergaard, Kaspar Rufibach, Walter P Maksymowych

Annals of the Rheumatic Diseases Jun 2015, 74 (6) 985-992; DOI: 10.1136/annrheumdis-2013-203887
Development of a health index in patients with ankylosing spondylitis (ASAS HI): final result of a global initiative based on the ICF guided by ASAS
U Kiltz, D van der Heijde, A Boonen, A Cieza, G Stucki, M A Khan, W P Maksymowych, H Marzo-Ortega, J Reveille, S Stebbings, C Bostan, J Braun

Annals of the Rheumatic Diseases May 2015, 74 (5) 830-835; DOI: 10.1136/annrheumdis-2013-203967
Gastrointestinal events in at-risk patients starting non-steroidal anti-inflammatory drugs (NSAIDs) for rheumatic diseases: the EVIDENCE study of European routine practice
Angel Lanas, Maarten Boers, Javier Nuevo

Annals of the Rheumatic Diseases Apr 2015, 74 (4) 675-681; DOI: 10.1136/annrheumdis-2013-204155
Golimumab administered subcutaneously every 4 weeks in ankylosing spondylitis: 5-year results of the GO-RAISE study
Atul Deodhar, Jürgen Braun, Robert D Inman, Désirée van der Heijde, Yiying Zhou, Stephen Xu, Chenglong Han, Benjamin Hsu

Annals of the Rheumatic Diseases Apr 2015, 74 (4) 757-761; DOI: 10.1136/annrheumdis-2014-205862
A6.13 Effects of anti-tnf therapy on circulating oxLDL-BETA2GPI complex levels in arthritis
A Pusztai, E Végh, A Váncsa, N Bodnár, S Szamosi, G Nagy, I Szöllösi, P Csomor, L Lopez, E Matsuura, G Szűcs, S Szántó, Z Nagy, Y Shoenfeld, Z Szekanecz

Annals of the Rheumatic Diseases Mar 2015, 74 (Suppl 1) A60-A61; DOI: 10.1136/annrheumdis-2015-207259.139
A6.12 Effects of anti-tnf therapy on markers of angiogenesis and vascular pathology in arthritis: a comparative approach
E Balogh, E Végh, G Kerekes, A Váncsa, P Csomor, L Pogácsás, F Balázs, J McCormick, M Biniecka, S Szántó, G Szűcs, U Fearon, DJ Veale, Z Szekanecz

Annals of the Rheumatic Diseases Mar 2015, 74 (Suppl 1) A60; DOI: 10.1136/annrheumdis-2015-207259.138
A6.26 Analysis of circulating mirnas in patients with axial sponyloarthritis with different spinal involvement
K Prajzlerová, M Fojtíková, S Forejtová, K Pavelka, J Vencovský, L Šenolt, M Filková

Annals of the Rheumatic Diseases Mar 2015, 74 (Suppl 1) A66; DOI: 10.1136/annrheumdis-2015-207259.152
A6.33 Changes in Hyaluronan metabolism is associated with inflammatory cytokines in patients with ankylosing spondylitis
U Hellman, D Hedqvist, B Sundström, L Do, S Wållberg-Jonsson

Annals of the Rheumatic Diseases Mar 2015, 74 (Suppl 1) A69; DOI: 10.1136/annrheumdis-2015-207259.159
A4.3 Effects of anti-TNF therapy on markers of bone homeostasis in rheumatoid arthritis and ankylosing spondylitis
Horváth Á, A Pusztai, K Gulyás, A Váncsa, E Végh, N Bodnár, P Csomor, Z Pethő, B Juhász, Á Szentpétery, S Szamosi, H Bhattoa, S Szántó, G Szűcs, Z Nagy, Z Szekanecz

Annals of the Rheumatic Diseases Mar 2015, 74 (Suppl 1) A37; DOI: 10.1136/annrheumdis-2015-207259.85

Main menu

Ankylosing spondylitis

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

Ankylosing spondylitis

Pages